The day before announcing Zyn’s marketing authorization, FDA Center for Tobacco Products announced another proposed rule that could have a massive impact on public health: a product standard that ...

The agency OK’d an artificial vessel to restore blood flow in patients, even though its own scientists flagged questionable ...

CINCINNATI (WKRC) - Customs and Border Protection officers have seized more than 100,000 pills that are not approved by the ...

New medicines are being developed for individual treatments based on someone’s DNA. Those would be allowed under a proposed ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Weight loss “wonder drug” Wegovy will cost Irish users around €220 a month as it is not currently availably under either the ...

According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ongoing clinical studies aimed at expanding its use beyond acute pain management.

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

Actavis Labs. FL, Inc. v. United States, Appeal No. 2023-1320 (Fed. Cir. Mar. 21, 2025) Our Case of the Week, in the words of ...

Industry leaders say the government failed to protect Thomas Cooper, 5, from dying in a hyperbaric chamber fire at the Oxford ...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

When combined with trastuzumab and chemotherapy, treatment with pembrolizumab was associated with a statistically significant improvement in PFS and OS compared with placebo.